Search

The Gene: An Intimate History is a new four-hour documentary from the award-winning Ken Burns team and PBS, adapted from the award-winning book of the same name by Siddhartha Mukherjee, MD, DPhil. Memorial Sloan Kettering’s Luis Alberto Diaz, Jr., MD, Head of the Division of Solid Tumor Oncology, is a featured expert.

… Monday, April 13, 2020 The Gene: An Intimate History is a new four-hour documentary from the award-winning Ken Burns team and PBS, adapted from the award-winning book of the same name by Siddhartha Mukherjee, MD, DPhil. The two-part series brings to life a historical biography of the human genome while

By assuming primitive regenerative identities, cancer cells gain the adaptability they need to establish tumors in new parts of the body.

… Monday, February 10, 2020 Summary Scientists have discovered that cancer cells rely on the biology of regeneration, wound healing, and embryonic development to spread to other organs and escape detection by the immune system. Just as people tend to become stuck in their ways as they grow older so too

TV anchor Al Roker discusses his own prostate cancer experiences, disparities in cancer care and outcomes for people of color, the importance of cancer screening for Black men, and more with Dr. Carol Brown, a gynecological oncology surgeon at Memorial Sloan Kettering and Nicholls-Biondi Chair for Health Equity at Memorial Sloan Kettering.

… Friday, February 12, 2021 VIDEO | 05:26 Health Equity and Cancer — A Conversation with Al Roker and Dr. Carol Brown Watch this video to hear NBC's Al Roker and MSK's Dr. Carol Brown discuss health disparities. Video Details When beloved TV anchor Al Roker of NBC News’ TODAY publicly announced that he

Targeting the cancer environment, rather than the cancer itself, could be a new avenue for immunotherapy.

… Wednesday, October 21, 2020 Summary Two MSK-led studies published in the journal Nature support the idea of using immunotherapy drugs to treat the environment surrounding a tumor as an indirect way to combat cancer. Despite the remarkable successes of immune-based treatments for cancer, not everyone

Learn about MSK thoracic surgeon Valerie Rusch and her approach to treating people with lung cancer and other tumors of the chest.

… Wednesday, August 28, 2019 Summary In an interview, MSK thoracic surgeon Valerie Rusch discusses her career path, her commitment to her patients, and her experiences as a woman in a male-dominated field. Valerie Rusch is Vice Chair for Clinical Research in the Department of Surgery at MSK. She is a thoracic

Research shows that TIL therapy, an emerging type of immunotherapy, works in some patients with non-small cell lung cancer.

… Wednesday, May 1, 2024 There is evidence that an emerging type of immunotherapy called TIL therapy may be successful in treating more solid tumors . Research published in Cancer Discovery shows this treatment works in some patients with non-small cell lung cancer . The lead researcher of the multicenter

Las investigaciones muestran que la terapia LIT, un tipo emergente de inmunoterapia, funciona en algunos pacientes con cáncer pulmonar de células no pequeñas.

… Wednesday, May 1, 2024 Hay evidencia de que un tipo emergente de inmunoterapia llamado terapia LIT podría ser exitoso en el tratamiento de tumores más sólidos . Una investigación publicada en Cancer Discovery demuestra que este tratamiento funciona en algunos pacientes con cáncer pulmonar de células

Doctors at MSK Kids, the dedicated pediatric service at Memorial Sloan Kettering Cancer Center (MSK), pioneered many advances for pediatric patients in 2022.

… Monday, January 30, 2023 Doctors at MSK Kids , the dedicated pediatric service at Memorial Sloan Kettering Cancer Center (MSK), pioneered many advances for pediatric patients in 2022. A combination of clinical trial findings and laboratory studies contributed to a greater understanding of the role that

New MSK research developed a deep-learning model designed to aid challenging cancer diagnoses; identified key regulators of infection-clearing immune cells; and shed new light on the mechanical forces exerted by immune cells.

… Monday, July 8, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) developed a deep-learning model designed to aid challenging cancer diagnoses; identified key regulators of infection-clearing immune cells; and shed new light on the mechanical forces exerted by immune cells. MSK-developed

Meet Fiona and Stanley Druckenmiller, whose latest venture supports promising new avenues of research for experts at Memorial Sloan Kettering Cancer Center.

… Friday, January 1, 2021 Fiona and Stanley Druckenmiller know the value of a good investment. Throughout their successful careers in finance, the Druckenmillers have lived by a key tenet: Invest in the causes and people you believe in. A passion for economics and keen analytical skills guided them throughout